Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR3.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR2.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR5.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR7.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR9.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR4.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR1.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR6.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR30.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR14.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR37.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR46.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR41.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR12.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR36.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR47.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR28.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR29.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR35.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR26.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR17.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR45.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR13.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR48.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR33.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR25.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR49.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR23.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR39.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR32.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR19.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR40.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR11.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR16.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR44.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR22.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR18.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR42.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR21.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR34.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR43.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR15.htm
EX-31.2 - EX-31.2 - ARIAD PHARMACEUTICALS INCd413091dex312.htm
EX-31.1 - EX-31.1 - ARIAD PHARMACEUTICALS INCd413091dex311.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR20.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR27.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR10.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR38.htm
10-Q - 10-Q - ARIAD PHARMACEUTICALS INCd413091d10q.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR8.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR24.htm
XML - IDEA: XBRL DOCUMENT - ARIAD PHARMACEUTICALS INCR31.htm

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the period ended September 30, 2012 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 9, 2012      

/s/ Harvey J. Berger, M.D

      Harvey J. Berger, M.D.
      Chairman and Chief Executive Officer
Date: November 9, 2012      

/s/ Edward M. Fitzgerald

      Edward M. Fitzgerald
      Executive Vice President,
      Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.